TABLE OF CONTENTS
Volume 14, Issue 1 (January 2007)
Review
Gene therapy in wound healing: present status and future directions
L K Branski, C T Pereira, D N Herndon and M G Jeschke
Gene Ther 14: 1-10; advance online publication, August 24, 2006; doi:10.1038/sj.gt.3302837
Original Articles
Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA
C-C Chen, T-M Ko, H-I Ma, H-L Wu, X Xiao, J Li, C-M Chang, P-Y Wu, C-H Chen, J-M Han, C-P Yu, K-S Jeng, C-P Hu and M-H Tao
Gene Ther 14: 11-19; advance online publication, August 24, 2006; doi:10.1038/sj.gt.3302846
Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice
C-F Hung, Y-C Tsai, L He, G Coukos, I Fodor, L Qin, H Levitsky and T-C Wu
Gene Ther 14: 20-29; advance online publication, August 17, 2006; doi:10.1038/sj.gt.3302840
Coxsackie adenovirus receptor and 
3/5 integrins in adenovirus gene transfer of rat cochlea
F Venail, J Wang, J Ruel, E Ballana, G Rebillard, M Eybalin, M Arbones, A Bosch and J-L Puel
Gene Ther 14: 30-37; advance online publication, August 3, 2006; doi:10.1038/sj.gt.3302826
Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes
G B Parsons, D W Souza, H Wu, D Yu, S G Wadsworth, R J Gregory and D Armentano
Gene Ther 14: 38-48; advance online publication, August 24, 2006; doi:10.1038/sj.gt.3302842
Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates
J Y Fischer-Lougheed, A F Tarantal, I Shulkin, N Mitsuhashi, D B Kohn, C C I Lee and M Kearns-Jonker
Gene Ther 14: 49-57; advance online publication, August 3, 2006; doi:10.1038/sj.gt.3302818
A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-
24, for the treatment of advanced breast cancer
T Ranki, A Kanerva, A Ristimäki, T Hakkarainen, M Särkioja, L Kangasniemi, M Raki, P Laakkonen, S Goodison and A Hemminki
Gene Ther 14: 58-67; advance online publication, August 10, 2006; doi:10.1038/sj.gt.3302830
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
H Hatakeyama, H Akita, K Kogure, M Oishi, Y Nagasaki, Y Kihira, M Ueno, H Kobayashi, H Kikuchi and H Harashima
Gene Ther 14: 68-77; advance online publication, August 17, 2006; doi:10.1038/sj.gt.3302843
Gene silencing by the tRNA maturase tRNase ZL under the direction of small-guide RNA
A Nakashima, H Takaku, H S Shibata, Y Negishi, M Takagi, M Tamura and M Nashimoto
Gene Ther 14: 78-85; advance online publication, August 3, 2006; doi:10.1038/sj.gt.3302841
Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants
N Solaroli, M Johansson, J Balzarini and A Karlsson
Gene Ther 14: 86-92; advance online publication, August 3, 2006; doi:10.1038/sj.gt.3302835
Short Communication
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35–55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice
R Furlan, A Bergami, E Brambilla, E Butti, M G De Simoni, M Campagnoli, P Marconi, G Comi and G Martino
Gene Ther 14: 93-98; advance online publication, August 24, 2006; doi:10.1038/sj.gt.3302805
